• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CONCORD MANUFACTURING LIBERTY SELECT CYCLER ASSY(NON-VALUATED); SYSTEM, PERITONEAL, AUTOMATIC DELIVERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CONCORD MANUFACTURING LIBERTY SELECT CYCLER ASSY(NON-VALUATED); SYSTEM, PERITONEAL, AUTOMATIC DELIVERY Back to Search Results
Model Number 180343
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Myocardial Infarction (1969)
Event Date 05/01/2022
Event Type  Death  
Manufacturer Narrative
Clinical review: a temporal relationship exists between ccpd therapy utilizing the liberty select cycler, and the patient¿s serious adverse events of an mi and death.Although the patient¿s cause of death was reportedly due to an mi, the cause of the mi is unknown; therefore, causality could not firmly be established.During follow-up the pdrn did not allege any fresenius device(s) and/or product(s) involvement.The esrd population continues to have significantly higher mortality, and fewer expected years of life when compared to the general population.Additionally, patients with esrd have a substantially higher incidence of acute coronary events (such as an mi), when compared to the general population.Based on the information available, the liberty select cycler cannot be disassociated from the events.There is no allegation or objective evidence indicating a fresenius device(s) and/or product(s) deficiency or malfunction caused the serious adverse events.However, given the lack of information (e.G., esrd death notification, definitive causality, death certificate, treatment data), the liberty select cycler cannot be excluded from having a possible causal or contributory role in the serious adverse events.The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.
 
Event Description
A relative of a peritoneal dialysis (pd) patient reported that the patient expired while undergoing continuous cyclic peritoneal dialysis [cc(pd)] for renal replacement therapy (rrt).During follow-up, a pd registered nurse (pdrn) confirmed the patient expired on (b)(6) 2022 due to a myocardial infarction (mi).Subsequent attempts to obtain additional information (e.G., discharge summary, treatment record, death certificate, esrd death notification) have thus far proven unsuccessful.
 
Manufacturer Narrative
Additional information: g.1.Plant investigation: no parts were returned to the manufacturer for physical evaluation.A records review was performed on the reported serial number.An investigation of the device manufacturing records was conducted by the manufacturer.There were no non-conformances, or any associated rework identified during the manufacturing process which could be related to the reported event.In addition, the device history record (dhr) review confirmed the results of the in-progress and final quality control (qc) testing met all requirements.The investigation into the cause of the reported problem was not able to be confirmed.A definitive conclusion regarding the complaint incident cannot be reached without a physical examination of the complaint device.
 
Event Description
A relative of a peritoneal dialysis (pd) patient reported that the patient expired while undergoing continuous cyclic peritoneal dialysis [cc(pd)] for renal replacement therapy (rrt).During follow-up, a pd registered nurse (pdrn) confirmed the patient expired on (b)(6) 2022 due to a myocardial infarction (mi).Subsequent attempts to obtain additional information (e.G., discharge summary, treatment record, death certificate, esrd death notification) have thus far proven unsuccessful.
 
Event Description
A relative of a peritoneal dialysis (pd) patient reported that the patient expired while undergoing continuous cyclic peritoneal dialysis [cc(pd)] for renal replacement therapy (rrt).During follow-up, a pd registered nurse (pdrn) confirmed the patient expired on (b)(6) 2022 due to a myocardial infarction (mi).Subsequent attempts to obtain additional information (e.G., discharge summary, treatment record, death certificate, esrd death notification) have thus far proven unsuccessful.
 
Manufacturer Narrative
Plant investigation: the actual device was returned to the manufacturer for physical evaluation.A visual inspection of the returned cycler exterior showed no sign of physical damage.Valve actuation test passed.System air leak test passed.Teach pump test passed.An (as-received) simulated treatment was performed and completed without failures.The cycler weighed fill volume values were within tolerance for a liberty cycler.The cycler was able to complete the treatment without issues.There were no visual discrepancies encountered during the internal inspection.A review of the device manufacturing records was conducted by the manufacturer.There were no deviations or non-conformances during the manufacturing process.In addition, a device history record (dhr) review was performed and verified that the results of the in-progress and final quality control (qc) testing met all requirements.Upon completion of the evaluation, there were no malfunctions that could have caused or contributed to the reported event.The cycler performed as designed and an associated cause could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIBERTY SELECT CYCLER ASSY(NON-VALUATED)
Type of Device
SYSTEM, PERITONEAL, AUTOMATIC DELIVERY
Manufacturer (Section D)
CONCORD MANUFACTURING
director, quality systems
4040 nelson avenue
concord CA 94520
Manufacturer (Section G)
CONCORD MANUFACTURING
director, quality systems
4040 nelson avenue
concord CA 94520
Manufacturer Contact
jessica trujillo
920 winter st
waltham, MA 02451
6174175172
MDR Report Key14411755
MDR Text Key291754290
Report Number0002937457-2022-00783
Device Sequence Number1
Product Code FKX
UDI-Device Identifier00840861102068
UDI-Public00840861102068
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K181108
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,Health Professional,User Facility,Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date 09/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model Number180343
Device Catalogue NumberRTLR180343
Was Device Available for Evaluation? Device Returned to Manufacturer
Device AgeMO
Initial Date Manufacturer Received 05/01/2022
Initial Date FDA Received05/16/2022
Supplement Dates Manufacturer Received05/20/2022
09/09/2022
Supplement Dates FDA Received06/01/2022
09/09/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/23/2017
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
DELFLEX PD FLUID; DELFLEX PD FLUID; DELFLEX PD FLUID; LIBERTY CYCLER SET; LIBERTY CYCLER SET; LIBERTY CYCLER SET
Patient Outcome(s) Death;
Patient SexFemale
-
-